Global Dyslexia Treatment Market
Global Dyslexia Treatment Market

Dyslexia Treatment Comprehensive Study by Type (Phonological Dyslexia, Surface Dyslexia), Treatment (Drug Class, Tools, Educational Techniques), End-users (Hospitals, Home Care, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Other) Players and Region - Global Market Outlook to 2026

Dyslexia Treatment Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Apr 2021 Edition 219 Pages 216 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Dyslexia Treatment?
It is estimated that a staggering 5 to 15 percent of Americans14.5 to 43.5 million children and adults have dyslexia disorder. Dyslexia is a specific learning disorder that leads to difficulty reading due to problems identifying speech sounds and learning how they relate to letters and words (decoding). It is a neurological issue making it more difficult to recognize, spell, and decode words. This disorder present at birth and cannot be cured or prevented, but it can be managed with special instructions and support. The factors such as Increased Prevalence of Dyslexia Worldwide, Rise in the Number of New Diagnostic Centres and Hospitals and Growth in Healthcare Infrastructure in Developing Regions are the key drivers for the global Dyslexia Treatment market.

The market study is broken down by Type (Phonological Dyslexia and Surface Dyslexia) and major geographies with country level break-up.

The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Research Analyst at AMA estimates that Players from United States will contribute to the maximum growth of Global Dyslexia Treatment market throughout the predicted period.

Teva Pharmaceutical Industries Ltd (Israel), Eli Lilly & Company (United States), Novartis AG (United Kingdom), Purdue Pharma (United States), Pfizer Inc. (United States), Jubilant Cadista (United States), Micro Labs (India), Srikem Labs (India), Gangwal Chemicals Pvt. Ltd (India), RPG Life Sciences Ltd (India), Wallace Pharmaceuticals Ltd (United States), Cian Healthcare Pvt Ltd (India) and GlaxoSmithKline (United Kingdom) are some of the key players that are part of study coverage.

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Dyslexia Treatment market by Type, Application and Region.

On the basis of geography, the market of Dyslexia Treatment has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Treatment, the sub-segment i.e. Drug Class will boost the Dyslexia Treatment market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End-users, the sub-segment i.e. Hospitals will boost the Dyslexia Treatment market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Distribution Channel, the sub-segment i.e. Hospital Pharmacies will boost the Dyslexia Treatment market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.




Market Trend
  • Increasing Awareness about Dyslexia and its Treatment Options among People

Market Drivers
  • Increased Prevalence of Dyslexia Worldwide
  • Rise in the Number of New Diagnostic Centres and Hospitals
  • Growth in Healthcare Infrastructure in Developing Regions

Opportunities
  • Increased Research and Development Funding
  • Growth in the Healthcare Industry Worldwide
  • Increasing Government Initiatives for Dyslexia Awareness

Restraints
  • Unavailability of Complete Cure for Dyslexia Disorder

Challenges
  • Lack of Healthcare Infrastructure in Underdeveloped Countries


Key Target Audience
Dyslexia Treatment Providers, Distributors, Emerging Companies, Research Professionals and End-users

About Approach
During this study the evaluation and validation of the market size is done through various sources including primary and secondary analysis. AMA Research & Media follows industrial and regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Phonological Dyslexia
  • Surface Dyslexia
By Treatment
  • Drug Class
  • Tools
  • Educational Techniques

By End-users
  • Hospitals
  • Home Care
  • Others

By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Other

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increased Prevalence of Dyslexia Worldwide
      • 3.2.2. Rise in the Number of New Diagnostic Centres and Hospitals
      • 3.2.3. Growth in Healthcare Infrastructure in Developing Regions
    • 3.3. Market Challenges
      • 3.3.1. Lack of Healthcare Infrastructure in Underdeveloped Countries
    • 3.4. Market Trends
      • 3.4.1. Increasing Awareness about Dyslexia and its Treatment Options among People
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Dyslexia Treatment, by Type, Treatment, End-users, Distribution Channel and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Dyslexia Treatment (Value)
      • 5.2.1. Global Dyslexia Treatment by: Type (Value)
        • 5.2.1.1. Phonological Dyslexia
        • 5.2.1.2. Surface Dyslexia
      • 5.2.2. Global Dyslexia Treatment by: Treatment (Value)
        • 5.2.2.1. Drug Class
        • 5.2.2.2. Tools
        • 5.2.2.3. Educational Techniques
      • 5.2.3. Global Dyslexia Treatment by: End-users (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Home Care
        • 5.2.3.3. Others
      • 5.2.4. Global Dyslexia Treatment by: Distribution Channel (Value)
        • 5.2.4.1. Hospital Pharmacies
        • 5.2.4.2. Retail Pharmacies
        • 5.2.4.3. Other
      • 5.2.5. Global Dyslexia Treatment Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Dyslexia Treatment: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Teva Pharmaceutical Industries Ltd (Israel)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Eli Lilly & Company (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Novartis AG (United Kingdom)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Purdue Pharma (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Pfizer Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Jubilant Cadista (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Micro Labs (India)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Srikem Labs (India)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Gangwal Chemicals Pvt. Ltd (India)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. RPG Life Sciences Ltd (India)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Wallace Pharmaceuticals Ltd (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Cian Healthcare Pvt Ltd (India)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. GlaxoSmithKline (United Kingdom)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
  • 7. Global Dyslexia Treatment Sale, by Type, Treatment, End-users, Distribution Channel and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Dyslexia Treatment (Value)
      • 7.2.1. Global Dyslexia Treatment by: Type (Value)
        • 7.2.1.1. Phonological Dyslexia
        • 7.2.1.2. Surface Dyslexia
      • 7.2.2. Global Dyslexia Treatment by: Treatment (Value)
        • 7.2.2.1. Drug Class
        • 7.2.2.2. Tools
        • 7.2.2.3. Educational Techniques
      • 7.2.3. Global Dyslexia Treatment by: End-users (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Home Care
        • 7.2.3.3. Others
      • 7.2.4. Global Dyslexia Treatment by: Distribution Channel (Value)
        • 7.2.4.1. Hospital Pharmacies
        • 7.2.4.2. Retail Pharmacies
        • 7.2.4.3. Other
      • 7.2.5. Global Dyslexia Treatment Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Dyslexia Treatment: by Type(USD Million)
  • Table 2. Dyslexia Treatment Phonological Dyslexia , by Region USD Million (2015-2020)
  • Table 3. Dyslexia Treatment Surface Dyslexia , by Region USD Million (2015-2020)
  • Table 4. Dyslexia Treatment: by Treatment(USD Million)
  • Table 5. Dyslexia Treatment Drug Class , by Region USD Million (2015-2020)
  • Table 6. Dyslexia Treatment Tools , by Region USD Million (2015-2020)
  • Table 7. Dyslexia Treatment Educational Techniques , by Region USD Million (2015-2020)
  • Table 8. Dyslexia Treatment: by End-users(USD Million)
  • Table 9. Dyslexia Treatment Hospitals , by Region USD Million (2015-2020)
  • Table 10. Dyslexia Treatment Home Care , by Region USD Million (2015-2020)
  • Table 11. Dyslexia Treatment Others , by Region USD Million (2015-2020)
  • Table 12. Dyslexia Treatment: by Distribution Channel(USD Million)
  • Table 13. Dyslexia Treatment Hospital Pharmacies , by Region USD Million (2015-2020)
  • Table 14. Dyslexia Treatment Retail Pharmacies , by Region USD Million (2015-2020)
  • Table 15. Dyslexia Treatment Other , by Region USD Million (2015-2020)
  • Table 16. South America Dyslexia Treatment, by Country USD Million (2015-2020)
  • Table 17. South America Dyslexia Treatment, by Type USD Million (2015-2020)
  • Table 18. South America Dyslexia Treatment, by Treatment USD Million (2015-2020)
  • Table 19. South America Dyslexia Treatment, by End-users USD Million (2015-2020)
  • Table 20. South America Dyslexia Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 21. Brazil Dyslexia Treatment, by Type USD Million (2015-2020)
  • Table 22. Brazil Dyslexia Treatment, by Treatment USD Million (2015-2020)
  • Table 23. Brazil Dyslexia Treatment, by End-users USD Million (2015-2020)
  • Table 24. Brazil Dyslexia Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 25. Argentina Dyslexia Treatment, by Type USD Million (2015-2020)
  • Table 26. Argentina Dyslexia Treatment, by Treatment USD Million (2015-2020)
  • Table 27. Argentina Dyslexia Treatment, by End-users USD Million (2015-2020)
  • Table 28. Argentina Dyslexia Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 29. Rest of South America Dyslexia Treatment, by Type USD Million (2015-2020)
  • Table 30. Rest of South America Dyslexia Treatment, by Treatment USD Million (2015-2020)
  • Table 31. Rest of South America Dyslexia Treatment, by End-users USD Million (2015-2020)
  • Table 32. Rest of South America Dyslexia Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 33. Asia Pacific Dyslexia Treatment, by Country USD Million (2015-2020)
  • Table 34. Asia Pacific Dyslexia Treatment, by Type USD Million (2015-2020)
  • Table 35. Asia Pacific Dyslexia Treatment, by Treatment USD Million (2015-2020)
  • Table 36. Asia Pacific Dyslexia Treatment, by End-users USD Million (2015-2020)
  • Table 37. Asia Pacific Dyslexia Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 38. China Dyslexia Treatment, by Type USD Million (2015-2020)
  • Table 39. China Dyslexia Treatment, by Treatment USD Million (2015-2020)
  • Table 40. China Dyslexia Treatment, by End-users USD Million (2015-2020)
  • Table 41. China Dyslexia Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 42. Japan Dyslexia Treatment, by Type USD Million (2015-2020)
  • Table 43. Japan Dyslexia Treatment, by Treatment USD Million (2015-2020)
  • Table 44. Japan Dyslexia Treatment, by End-users USD Million (2015-2020)
  • Table 45. Japan Dyslexia Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 46. India Dyslexia Treatment, by Type USD Million (2015-2020)
  • Table 47. India Dyslexia Treatment, by Treatment USD Million (2015-2020)
  • Table 48. India Dyslexia Treatment, by End-users USD Million (2015-2020)
  • Table 49. India Dyslexia Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 50. South Korea Dyslexia Treatment, by Type USD Million (2015-2020)
  • Table 51. South Korea Dyslexia Treatment, by Treatment USD Million (2015-2020)
  • Table 52. South Korea Dyslexia Treatment, by End-users USD Million (2015-2020)
  • Table 53. South Korea Dyslexia Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 54. Taiwan Dyslexia Treatment, by Type USD Million (2015-2020)
  • Table 55. Taiwan Dyslexia Treatment, by Treatment USD Million (2015-2020)
  • Table 56. Taiwan Dyslexia Treatment, by End-users USD Million (2015-2020)
  • Table 57. Taiwan Dyslexia Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 58. Australia Dyslexia Treatment, by Type USD Million (2015-2020)
  • Table 59. Australia Dyslexia Treatment, by Treatment USD Million (2015-2020)
  • Table 60. Australia Dyslexia Treatment, by End-users USD Million (2015-2020)
  • Table 61. Australia Dyslexia Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 62. Rest of Asia-Pacific Dyslexia Treatment, by Type USD Million (2015-2020)
  • Table 63. Rest of Asia-Pacific Dyslexia Treatment, by Treatment USD Million (2015-2020)
  • Table 64. Rest of Asia-Pacific Dyslexia Treatment, by End-users USD Million (2015-2020)
  • Table 65. Rest of Asia-Pacific Dyslexia Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 66. Europe Dyslexia Treatment, by Country USD Million (2015-2020)
  • Table 67. Europe Dyslexia Treatment, by Type USD Million (2015-2020)
  • Table 68. Europe Dyslexia Treatment, by Treatment USD Million (2015-2020)
  • Table 69. Europe Dyslexia Treatment, by End-users USD Million (2015-2020)
  • Table 70. Europe Dyslexia Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 71. Germany Dyslexia Treatment, by Type USD Million (2015-2020)
  • Table 72. Germany Dyslexia Treatment, by Treatment USD Million (2015-2020)
  • Table 73. Germany Dyslexia Treatment, by End-users USD Million (2015-2020)
  • Table 74. Germany Dyslexia Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 75. France Dyslexia Treatment, by Type USD Million (2015-2020)
  • Table 76. France Dyslexia Treatment, by Treatment USD Million (2015-2020)
  • Table 77. France Dyslexia Treatment, by End-users USD Million (2015-2020)
  • Table 78. France Dyslexia Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 79. Italy Dyslexia Treatment, by Type USD Million (2015-2020)
  • Table 80. Italy Dyslexia Treatment, by Treatment USD Million (2015-2020)
  • Table 81. Italy Dyslexia Treatment, by End-users USD Million (2015-2020)
  • Table 82. Italy Dyslexia Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 83. United Kingdom Dyslexia Treatment, by Type USD Million (2015-2020)
  • Table 84. United Kingdom Dyslexia Treatment, by Treatment USD Million (2015-2020)
  • Table 85. United Kingdom Dyslexia Treatment, by End-users USD Million (2015-2020)
  • Table 86. United Kingdom Dyslexia Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 87. Netherlands Dyslexia Treatment, by Type USD Million (2015-2020)
  • Table 88. Netherlands Dyslexia Treatment, by Treatment USD Million (2015-2020)
  • Table 89. Netherlands Dyslexia Treatment, by End-users USD Million (2015-2020)
  • Table 90. Netherlands Dyslexia Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 91. Rest of Europe Dyslexia Treatment, by Type USD Million (2015-2020)
  • Table 92. Rest of Europe Dyslexia Treatment, by Treatment USD Million (2015-2020)
  • Table 93. Rest of Europe Dyslexia Treatment, by End-users USD Million (2015-2020)
  • Table 94. Rest of Europe Dyslexia Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 95. MEA Dyslexia Treatment, by Country USD Million (2015-2020)
  • Table 96. MEA Dyslexia Treatment, by Type USD Million (2015-2020)
  • Table 97. MEA Dyslexia Treatment, by Treatment USD Million (2015-2020)
  • Table 98. MEA Dyslexia Treatment, by End-users USD Million (2015-2020)
  • Table 99. MEA Dyslexia Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 100. Middle East Dyslexia Treatment, by Type USD Million (2015-2020)
  • Table 101. Middle East Dyslexia Treatment, by Treatment USD Million (2015-2020)
  • Table 102. Middle East Dyslexia Treatment, by End-users USD Million (2015-2020)
  • Table 103. Middle East Dyslexia Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 104. Africa Dyslexia Treatment, by Type USD Million (2015-2020)
  • Table 105. Africa Dyslexia Treatment, by Treatment USD Million (2015-2020)
  • Table 106. Africa Dyslexia Treatment, by End-users USD Million (2015-2020)
  • Table 107. Africa Dyslexia Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 108. North America Dyslexia Treatment, by Country USD Million (2015-2020)
  • Table 109. North America Dyslexia Treatment, by Type USD Million (2015-2020)
  • Table 110. North America Dyslexia Treatment, by Treatment USD Million (2015-2020)
  • Table 111. North America Dyslexia Treatment, by End-users USD Million (2015-2020)
  • Table 112. North America Dyslexia Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 113. United States Dyslexia Treatment, by Type USD Million (2015-2020)
  • Table 114. United States Dyslexia Treatment, by Treatment USD Million (2015-2020)
  • Table 115. United States Dyslexia Treatment, by End-users USD Million (2015-2020)
  • Table 116. United States Dyslexia Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 117. Canada Dyslexia Treatment, by Type USD Million (2015-2020)
  • Table 118. Canada Dyslexia Treatment, by Treatment USD Million (2015-2020)
  • Table 119. Canada Dyslexia Treatment, by End-users USD Million (2015-2020)
  • Table 120. Canada Dyslexia Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 121. Mexico Dyslexia Treatment, by Type USD Million (2015-2020)
  • Table 122. Mexico Dyslexia Treatment, by Treatment USD Million (2015-2020)
  • Table 123. Mexico Dyslexia Treatment, by End-users USD Million (2015-2020)
  • Table 124. Mexico Dyslexia Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 125. Company Basic Information, Sales Area and Its Competitors
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Dyslexia Treatment: by Type(USD Million)
  • Table 139. Dyslexia Treatment Phonological Dyslexia , by Region USD Million (2021-2026)
  • Table 140. Dyslexia Treatment Surface Dyslexia , by Region USD Million (2021-2026)
  • Table 141. Dyslexia Treatment: by Treatment(USD Million)
  • Table 142. Dyslexia Treatment Drug Class , by Region USD Million (2021-2026)
  • Table 143. Dyslexia Treatment Tools , by Region USD Million (2021-2026)
  • Table 144. Dyslexia Treatment Educational Techniques , by Region USD Million (2021-2026)
  • Table 145. Dyslexia Treatment: by End-users(USD Million)
  • Table 146. Dyslexia Treatment Hospitals , by Region USD Million (2021-2026)
  • Table 147. Dyslexia Treatment Home Care , by Region USD Million (2021-2026)
  • Table 148. Dyslexia Treatment Others , by Region USD Million (2021-2026)
  • Table 149. Dyslexia Treatment: by Distribution Channel(USD Million)
  • Table 150. Dyslexia Treatment Hospital Pharmacies , by Region USD Million (2021-2026)
  • Table 151. Dyslexia Treatment Retail Pharmacies , by Region USD Million (2021-2026)
  • Table 152. Dyslexia Treatment Other , by Region USD Million (2021-2026)
  • Table 153. South America Dyslexia Treatment, by Country USD Million (2021-2026)
  • Table 154. South America Dyslexia Treatment, by Type USD Million (2021-2026)
  • Table 155. South America Dyslexia Treatment, by Treatment USD Million (2021-2026)
  • Table 156. South America Dyslexia Treatment, by End-users USD Million (2021-2026)
  • Table 157. South America Dyslexia Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 158. Brazil Dyslexia Treatment, by Type USD Million (2021-2026)
  • Table 159. Brazil Dyslexia Treatment, by Treatment USD Million (2021-2026)
  • Table 160. Brazil Dyslexia Treatment, by End-users USD Million (2021-2026)
  • Table 161. Brazil Dyslexia Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 162. Argentina Dyslexia Treatment, by Type USD Million (2021-2026)
  • Table 163. Argentina Dyslexia Treatment, by Treatment USD Million (2021-2026)
  • Table 164. Argentina Dyslexia Treatment, by End-users USD Million (2021-2026)
  • Table 165. Argentina Dyslexia Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 166. Rest of South America Dyslexia Treatment, by Type USD Million (2021-2026)
  • Table 167. Rest of South America Dyslexia Treatment, by Treatment USD Million (2021-2026)
  • Table 168. Rest of South America Dyslexia Treatment, by End-users USD Million (2021-2026)
  • Table 169. Rest of South America Dyslexia Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 170. Asia Pacific Dyslexia Treatment, by Country USD Million (2021-2026)
  • Table 171. Asia Pacific Dyslexia Treatment, by Type USD Million (2021-2026)
  • Table 172. Asia Pacific Dyslexia Treatment, by Treatment USD Million (2021-2026)
  • Table 173. Asia Pacific Dyslexia Treatment, by End-users USD Million (2021-2026)
  • Table 174. Asia Pacific Dyslexia Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 175. China Dyslexia Treatment, by Type USD Million (2021-2026)
  • Table 176. China Dyslexia Treatment, by Treatment USD Million (2021-2026)
  • Table 177. China Dyslexia Treatment, by End-users USD Million (2021-2026)
  • Table 178. China Dyslexia Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 179. Japan Dyslexia Treatment, by Type USD Million (2021-2026)
  • Table 180. Japan Dyslexia Treatment, by Treatment USD Million (2021-2026)
  • Table 181. Japan Dyslexia Treatment, by End-users USD Million (2021-2026)
  • Table 182. Japan Dyslexia Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 183. India Dyslexia Treatment, by Type USD Million (2021-2026)
  • Table 184. India Dyslexia Treatment, by Treatment USD Million (2021-2026)
  • Table 185. India Dyslexia Treatment, by End-users USD Million (2021-2026)
  • Table 186. India Dyslexia Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 187. South Korea Dyslexia Treatment, by Type USD Million (2021-2026)
  • Table 188. South Korea Dyslexia Treatment, by Treatment USD Million (2021-2026)
  • Table 189. South Korea Dyslexia Treatment, by End-users USD Million (2021-2026)
  • Table 190. South Korea Dyslexia Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 191. Taiwan Dyslexia Treatment, by Type USD Million (2021-2026)
  • Table 192. Taiwan Dyslexia Treatment, by Treatment USD Million (2021-2026)
  • Table 193. Taiwan Dyslexia Treatment, by End-users USD Million (2021-2026)
  • Table 194. Taiwan Dyslexia Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 195. Australia Dyslexia Treatment, by Type USD Million (2021-2026)
  • Table 196. Australia Dyslexia Treatment, by Treatment USD Million (2021-2026)
  • Table 197. Australia Dyslexia Treatment, by End-users USD Million (2021-2026)
  • Table 198. Australia Dyslexia Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 199. Rest of Asia-Pacific Dyslexia Treatment, by Type USD Million (2021-2026)
  • Table 200. Rest of Asia-Pacific Dyslexia Treatment, by Treatment USD Million (2021-2026)
  • Table 201. Rest of Asia-Pacific Dyslexia Treatment, by End-users USD Million (2021-2026)
  • Table 202. Rest of Asia-Pacific Dyslexia Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 203. Europe Dyslexia Treatment, by Country USD Million (2021-2026)
  • Table 204. Europe Dyslexia Treatment, by Type USD Million (2021-2026)
  • Table 205. Europe Dyslexia Treatment, by Treatment USD Million (2021-2026)
  • Table 206. Europe Dyslexia Treatment, by End-users USD Million (2021-2026)
  • Table 207. Europe Dyslexia Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 208. Germany Dyslexia Treatment, by Type USD Million (2021-2026)
  • Table 209. Germany Dyslexia Treatment, by Treatment USD Million (2021-2026)
  • Table 210. Germany Dyslexia Treatment, by End-users USD Million (2021-2026)
  • Table 211. Germany Dyslexia Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 212. France Dyslexia Treatment, by Type USD Million (2021-2026)
  • Table 213. France Dyslexia Treatment, by Treatment USD Million (2021-2026)
  • Table 214. France Dyslexia Treatment, by End-users USD Million (2021-2026)
  • Table 215. France Dyslexia Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 216. Italy Dyslexia Treatment, by Type USD Million (2021-2026)
  • Table 217. Italy Dyslexia Treatment, by Treatment USD Million (2021-2026)
  • Table 218. Italy Dyslexia Treatment, by End-users USD Million (2021-2026)
  • Table 219. Italy Dyslexia Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 220. United Kingdom Dyslexia Treatment, by Type USD Million (2021-2026)
  • Table 221. United Kingdom Dyslexia Treatment, by Treatment USD Million (2021-2026)
  • Table 222. United Kingdom Dyslexia Treatment, by End-users USD Million (2021-2026)
  • Table 223. United Kingdom Dyslexia Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 224. Netherlands Dyslexia Treatment, by Type USD Million (2021-2026)
  • Table 225. Netherlands Dyslexia Treatment, by Treatment USD Million (2021-2026)
  • Table 226. Netherlands Dyslexia Treatment, by End-users USD Million (2021-2026)
  • Table 227. Netherlands Dyslexia Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 228. Rest of Europe Dyslexia Treatment, by Type USD Million (2021-2026)
  • Table 229. Rest of Europe Dyslexia Treatment, by Treatment USD Million (2021-2026)
  • Table 230. Rest of Europe Dyslexia Treatment, by End-users USD Million (2021-2026)
  • Table 231. Rest of Europe Dyslexia Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 232. MEA Dyslexia Treatment, by Country USD Million (2021-2026)
  • Table 233. MEA Dyslexia Treatment, by Type USD Million (2021-2026)
  • Table 234. MEA Dyslexia Treatment, by Treatment USD Million (2021-2026)
  • Table 235. MEA Dyslexia Treatment, by End-users USD Million (2021-2026)
  • Table 236. MEA Dyslexia Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 237. Middle East Dyslexia Treatment, by Type USD Million (2021-2026)
  • Table 238. Middle East Dyslexia Treatment, by Treatment USD Million (2021-2026)
  • Table 239. Middle East Dyslexia Treatment, by End-users USD Million (2021-2026)
  • Table 240. Middle East Dyslexia Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 241. Africa Dyslexia Treatment, by Type USD Million (2021-2026)
  • Table 242. Africa Dyslexia Treatment, by Treatment USD Million (2021-2026)
  • Table 243. Africa Dyslexia Treatment, by End-users USD Million (2021-2026)
  • Table 244. Africa Dyslexia Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 245. North America Dyslexia Treatment, by Country USD Million (2021-2026)
  • Table 246. North America Dyslexia Treatment, by Type USD Million (2021-2026)
  • Table 247. North America Dyslexia Treatment, by Treatment USD Million (2021-2026)
  • Table 248. North America Dyslexia Treatment, by End-users USD Million (2021-2026)
  • Table 249. North America Dyslexia Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 250. United States Dyslexia Treatment, by Type USD Million (2021-2026)
  • Table 251. United States Dyslexia Treatment, by Treatment USD Million (2021-2026)
  • Table 252. United States Dyslexia Treatment, by End-users USD Million (2021-2026)
  • Table 253. United States Dyslexia Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 254. Canada Dyslexia Treatment, by Type USD Million (2021-2026)
  • Table 255. Canada Dyslexia Treatment, by Treatment USD Million (2021-2026)
  • Table 256. Canada Dyslexia Treatment, by End-users USD Million (2021-2026)
  • Table 257. Canada Dyslexia Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 258. Mexico Dyslexia Treatment, by Type USD Million (2021-2026)
  • Table 259. Mexico Dyslexia Treatment, by Treatment USD Million (2021-2026)
  • Table 260. Mexico Dyslexia Treatment, by End-users USD Million (2021-2026)
  • Table 261. Mexico Dyslexia Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 262. Research Programs/Design for This Report
  • Table 263. Key Data Information from Secondary Sources
  • Table 264. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Dyslexia Treatment: by Type USD Million (2015-2020)
  • Figure 5. Global Dyslexia Treatment: by Treatment USD Million (2015-2020)
  • Figure 6. Global Dyslexia Treatment: by End-users USD Million (2015-2020)
  • Figure 7. Global Dyslexia Treatment: by Distribution Channel USD Million (2015-2020)
  • Figure 8. South America Dyslexia Treatment Share (%), by Country
  • Figure 9. Asia Pacific Dyslexia Treatment Share (%), by Country
  • Figure 10. Europe Dyslexia Treatment Share (%), by Country
  • Figure 11. MEA Dyslexia Treatment Share (%), by Country
  • Figure 12. North America Dyslexia Treatment Share (%), by Country
  • Figure 13. Global Dyslexia Treatment share by Players 2020 (%)
  • Figure 14. Global Dyslexia Treatment share by Players (Top 3) 2020(%)
  • Figure 15. Global Dyslexia Treatment share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Teva Pharmaceutical Industries Ltd (Israel) Revenue, Net Income and Gross profit
  • Figure 18. Teva Pharmaceutical Industries Ltd (Israel) Revenue: by Geography 2020
  • Figure 19. Eli Lilly & Company (United States) Revenue, Net Income and Gross profit
  • Figure 20. Eli Lilly & Company (United States) Revenue: by Geography 2020
  • Figure 21. Novartis AG (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 22. Novartis AG (United Kingdom) Revenue: by Geography 2020
  • Figure 23. Purdue Pharma (United States) Revenue, Net Income and Gross profit
  • Figure 24. Purdue Pharma (United States) Revenue: by Geography 2020
  • Figure 25. Pfizer Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Pfizer Inc. (United States) Revenue: by Geography 2020
  • Figure 27. Jubilant Cadista (United States) Revenue, Net Income and Gross profit
  • Figure 28. Jubilant Cadista (United States) Revenue: by Geography 2020
  • Figure 29. Micro Labs (India) Revenue, Net Income and Gross profit
  • Figure 30. Micro Labs (India) Revenue: by Geography 2020
  • Figure 31. Srikem Labs (India) Revenue, Net Income and Gross profit
  • Figure 32. Srikem Labs (India) Revenue: by Geography 2020
  • Figure 33. Gangwal Chemicals Pvt. Ltd (India) Revenue, Net Income and Gross profit
  • Figure 34. Gangwal Chemicals Pvt. Ltd (India) Revenue: by Geography 2020
  • Figure 35. RPG Life Sciences Ltd (India) Revenue, Net Income and Gross profit
  • Figure 36. RPG Life Sciences Ltd (India) Revenue: by Geography 2020
  • Figure 37. Wallace Pharmaceuticals Ltd (United States) Revenue, Net Income and Gross profit
  • Figure 38. Wallace Pharmaceuticals Ltd (United States) Revenue: by Geography 2020
  • Figure 39. Cian Healthcare Pvt Ltd (India) Revenue, Net Income and Gross profit
  • Figure 40. Cian Healthcare Pvt Ltd (India) Revenue: by Geography 2020
  • Figure 41. GlaxoSmithKline (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 42. GlaxoSmithKline (United Kingdom) Revenue: by Geography 2020
  • Figure 43. Global Dyslexia Treatment: by Type USD Million (2021-2026)
  • Figure 44. Global Dyslexia Treatment: by Treatment USD Million (2021-2026)
  • Figure 45. Global Dyslexia Treatment: by End-users USD Million (2021-2026)
  • Figure 46. Global Dyslexia Treatment: by Distribution Channel USD Million (2021-2026)
  • Figure 47. South America Dyslexia Treatment Share (%), by Country
  • Figure 48. Asia Pacific Dyslexia Treatment Share (%), by Country
  • Figure 49. Europe Dyslexia Treatment Share (%), by Country
  • Figure 50. MEA Dyslexia Treatment Share (%), by Country
  • Figure 51. North America Dyslexia Treatment Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Teva Pharmaceutical Industries Ltd (Israel)
  • Eli Lilly & Company (United States)
  • Novartis AG (United Kingdom)
  • Purdue Pharma (United States)
  • Pfizer Inc. (United States)
  • Jubilant Cadista (United States)
  • Micro Labs (India)
  • Srikem Labs (India)
  • Gangwal Chemicals Pvt. Ltd (India)
  • RPG Life Sciences Ltd (India)
  • Wallace Pharmaceuticals Ltd (United States)
  • Cian Healthcare Pvt Ltd (India)
  • GlaxoSmithKline (United Kingdom)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation